DK379277A - Fremgangsmaade til fremstilling af prostaglandinanaloge - Google Patents

Fremgangsmaade til fremstilling af prostaglandinanaloge

Info

Publication number
DK379277A
DK379277A DK379277A DK379277A DK379277A DK 379277 A DK379277 A DK 379277A DK 379277 A DK379277 A DK 379277A DK 379277 A DK379277 A DK 379277A DK 379277 A DK379277 A DK 379277A
Authority
DK
Denmark
Prior art keywords
prostagland
analog
procedure
production
prostagland analog
Prior art date
Application number
DK379277A
Other languages
Danish (da)
English (en)
Inventor
M R Johnson
H J E Hess
J S Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK379277A publication Critical patent/DK379277A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
DK379277A 1976-08-27 1977-08-26 Fremgangsmaade til fremstilling af prostaglandinanaloge DK379277A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71813876A 1976-08-27 1976-08-27

Publications (1)

Publication Number Publication Date
DK379277A true DK379277A (da) 1978-02-28

Family

ID=24884966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK379277A DK379277A (da) 1976-08-27 1977-08-26 Fremgangsmaade til fremstilling af prostaglandinanaloge

Country Status (9)

Country Link
JP (1) JPS5328160A (nl)
BE (1) BE858146A (nl)
DE (1) DE2737807A1 (nl)
DK (1) DK379277A (nl)
FR (1) FR2362848A1 (nl)
GB (1) GB1545411A (nl)
IE (1) IE45965B1 (nl)
LU (1) LU78021A1 (nl)
NL (1) NL7709386A (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01008955A (es) 1999-03-05 2002-04-24 Procter & Gamble Analogos de prostaglandinas selectivas de fp no saturadas de c16.
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204816A1 (es) * 1972-11-08 1976-03-05 Pfizer Procedimiento para preparar una prostaglandina
GB1482010A (en) * 1974-10-28 1977-08-03 Ono Pharmaceutical Co Prostaglandin analogues

Also Published As

Publication number Publication date
FR2362848A1 (fr) 1978-03-24
FR2362848B1 (nl) 1980-07-11
JPS5328160A (en) 1978-03-16
IE45965B1 (en) 1983-01-12
BE858146A (fr) 1978-02-27
NL7709386A (nl) 1978-03-01
LU78021A1 (fr) 1979-05-23
DE2737807A1 (de) 1978-03-09
GB1545411A (en) 1979-05-10
IE45965L (en) 1978-02-27

Similar Documents

Publication Publication Date Title
DK492677A (da) Fremgangsmaade til fremstilling af substituerede benzam9der
DK320977A (da) Fremgangsmade til fremstilling af bindemidler til elektrodyppelakering
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK321177A (da) Fremgangsmade til fremstilling af bindemidler til elektrodyppelakering
DK207178A (da) Fremgangsmaade til fremstilling af sojaskraa
DK354678A (da) Fremgangsmaade til fremstilling af propenylaminer
DK405078A (da) Fremgangsmaade til fremstilling af prostaglandinanaloge
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK452578A (da) Fremgangsmaade til fremstilling af furanderivater
DK379477A (da) Fremgangsmaade il fremstilling af prostaglandinanaloge
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK192778A (da) Fremgangsmaade til fremstilling af bisamidiner
DK377978A (da) Fremgangsmaade til fremstilling af opskummede plaststoffer
DK476377A (da) Fremgangsmaade til fremstilling af krydslaminater
DK476277A (da) Fremgangsmaade til fremstilling af krydslaminater
DK575576A (da) Fremgangsmade til fremstilling af krystallinske former af natrium-cefamandol
DK379277A (da) Fremgangsmaade til fremstilling af prostaglandinanaloge
DK551677A (da) Fremgangsmaade til fremstilling af prostaglandinanaloge
DK87977A (da) Fremgangsmade til fremstilling af benzylestere
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK417477A (da) Fremgangsmaade til fremstilling af urethaner
DK73977A (da) Fremgangsmade til fremstilling af d-homosteroider
DK77179A (da) Fremgangsmaade til fremstilling af androstadiener